Clinical Trial

CYTALUX Dose Extension Study

Name: CYTALUX Dose Extension Study — clinical trial record (NCT07469202)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 4

View on ClinicalTrials.gov →

Summary

The goal of this clinical trial is to learn whether giving Cytalux™ (pafolacianine) injection several days before surgery works as well as giving it closer to the time of surgery for helping surgeons see lesions during an operation. This study is being done in adult patients undergoing surgery for malignant or non-malignant lung lesions or for confirmed ovarian cancer.

Trial Details

NCT Number	NCT07469202
Lead Sponsor	On Target Laboratories, LLC
Conditions	Cancer in the Lung, Ovarian Cancer
Enrollment	106 participants
Start Date	2026-05-15
Primary Completion	2026-11-30 (estimated)
Study Completion	2026-11-30 (estimated)
Updated on ClinicalTrials.gov	2026-03-13